Reaching optimal iodine nutrition in pregnant and lactating women and young children: programmatic recommendations by Untoro, Juliawati et al.
Editorial
Reaching optimal iodine nutrition in pregnant and lactating
women and young children: programmatic recommendations
The United Nations Children’s Fund (UNICEF) and the
World Health Organization (WHO) Joint Committee on
Health Policy recommended Universal Salt Iodization
(USI)1 as a safe, cost-effective and primary sustainable
strategy to ensure sufficient intake of iodine by all
individuals1. It was also suggested to consider temporary
iodine supplementation in areas of severe iodine
deficiency where USI cannot be rapidly implemented.
Although there has been considerable progress in the
prevention and control of Iodine Deficiency Disorders
(IDD) globally – over 70% households now use adequately
iodized salt – it is estimated that there are still about 39
million infants born each year unprotected from the risk
of cognitive damage from iodine deficiency.
Because of this and based on new evidence and lessons
learned within the last decade, it appears that the
most susceptible groups, pregnant and lactating women
and children less than two years of age, might not be
adequately covered by iodized salt where USI is not fully
implemented2–4. A fetus is totally dependent in early
pregnancy on maternal thyroxine for normal brain
development. Adequate maternal dietary intake of iodine
during pregnancy is essential for maternal thyroxine
production and later for thyroid function in the fetus. If
iodine insufficiency leads to inadequate production of
thyroid hormones and hypothyroidism during pregnancy,
then this is likely to result in irreversible fetal brain
damage5,6.
In order to address this issue, the WHO convened a
technical consultation on the prevention and control of
iodine deficiency in pregnant and lactating women and in
children less than two years old. The consultation, held on
24–26 January 2005, Geneva, Switzerland, made rec-
ommendations to ensure optimum iodine nutrition among
these groups and is reported in this issue7. As a follow up
to the meeting, and in order to provide programmatic
guidance to implement these recommendations within the
country programme planning process, UNICEF and WHO
held a joint meeting on 15–16 November 2005 at UNICEF
Headquarters, New York, USA. This editorial presents the
conclusions of the joint UNICEF/WHO meeting.
The primary strategy for sustainable elimination of
iodine deficiency remains USI8. In some countries and
areas, however, salt iodization programmes may not be
implementable, thus resulting in insufficient access to
iodine for some groups of the population2,9,10. In these
cases, besides strengthening the USI programmes,
additional complementary strategies such as iodine
supplementation should be considered by the country to
ensure optimal iodine nutrition for these susceptible
groups2,9,11,12. As the first step, countries need to assess
and categorize the level of implementation of salt
iodization programmes and, based on this analysis, should
revisit the strategy for IDD control, as necessary.
Categorization of country according to level of
implementation of salt iodization programmes
Countries or areas of countries can be categorized into
four groups based on the proportion of household use of
iodized salt at the national and sub-national levels. The
joint consultation concluded that it is preferable for highly
populated countries to use disaggregated data and
categorize areas of the country according to sub-national
(region, province, district) data:
Group I: Countries or areas of countries in which more
than 90% of the households have access to iodized salt.
Group II: Countries or areas of countries in which
50–90% of the households have access to iodized salt.
Group III: Countries or areas of countries in which
20–50% of the households have access to iodized salt.
Group IV: Countries or areas of countries in which less
than 20% of the households have access to iodized salt.
Guidelines for decision making on when and how to
plan for additional iodine intake in pregnant and
lactating women and children 7–24 months of age
Group I: The countries in this group should sustain the
achievement of USI and periodically reassess the salt
iodization programme and population iodine status.
Group II: The countries in this group should make
efforts to accelerate salt iodization based on the existing
operational guidelines8,13. If no progress in scaling up is
being made within two years, then the feasibility of
increasing iodine intake in the form of a supplement or
iodine fortified foods by the most susceptible groups–
pregnant and lactating women and children 7–24 months
q World Health Organization 2007
1Universal salt iodization (USI) means the iodization of salt for
consumption by both humans and animals
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of age–would need to be assessed, using the recom-
mended strategy for the countries of group III.
Group III: The countries in this group will need to assess
the feasibility of increasing iodine intake in the form of a
supplement or iodine fortified complementary foods by
the most susceptible groups, as described in the following
programmatic steps.
a. Assess population iodine nutrition status, house-
hold iodized salt coverage (preferably disaggre-
gated) and salt iodization programmes in order to
identify a national or sub-national problem. An
initial rapid assessment will be needed for
advocacy and for future monitoring, if no
assessment has yet been made. The methodology
of assessments is described in the ICCIDD/UNI-
CEF/WHO guidelines on Assessment of Iodine
Deficiency Disorders and Monitoring their Elimin-
ation13.
b. Develop new plans to strengthen salt iodization that
include increasing political commitment, advocacy,
capacity building of the salt industry for production
and quality assurance, adoption and enforcement of
appropriate regulations/legislation, and an effective
iodized-salt monitoring system at production (or
importation), retail and community levels.
c. The feasibility of increasing the iodine intake of
susceptible groups in the form of supplements or
iodine fortified food, will need to be explored as a
temporary measure while strengthening the salt
iodization programme. In areas of moderate IDD
(median urinary iodine less than 50mg/L or total
goitre rate more than 20%), the objective should be
to provide additional iodine in the form of a
supplement to all pregnant and lactating women,
and in the form of supplement or iodine fortified
complementary food for children of 7–24 months of
age.
d. Assessing the feasibility of providing additional iodine
should include: (i) costing of supplementation; (ii)
existing channels for distribution to reach the target
groups; (iii) likely duration of supplementation; and
(iv) potential compliance.
Group IV: Each country in this group should assess the
current situation of its salt iodization programme to
identify national or sub-national problems and to update
its strategies and action plans. The most vulnerable
groups, pregnant and lactating women, should be
supplemented with iodine and children 7–24 months of
age should be given either a supplement or complemen-
tary food fortified with iodine until the salt iodization
programme is scaled up.
Guidelines for decision making on when and how
to plan for additional iodine intake in pregnant
and lactating women and children 7–24 months
of age in specific situations
Irrespective of where countries or areas of countries
are categorized there are specific situations, such as in
emergencies, among displaced people and geographi-
cally remote areas where additional iodine intake should
be considered. If iodized salt is not accessible in these
specific situations, increasing iodine intake is required in
the form of iodine supplements for pregnant and
lactating women and a supplement or complementary
food fortified with iodine for children 7–24 months of
age. In cases where it is difficult to reach pregnant
women, supplementation to all women of reproductive
age is advised.
Recommended dosages of iodine supplement
The consultation agreed on two main approaches for
administering iodine supplementation on a daily basis or
an annual basis using an iodized oil preparation, and
endorsed the dose recommendations of the WHO as
described in Table 1 7.
Table 1 Recommended dosages of daily and annual iodine supplementation
Population group
Daily dose of iodine
supplement
(mg/d)
Single
annual
dose of iodized
oil supplement
(mg/y)
Pregnant women 250 400
Lactating women 250 400
Women of reproductive age (15–49 y) 150 400
Children ,2 y2,3 90 200
2 For children aged 0–6 months, iodine supplementation should be given through breast milk. This implies
that the child is exclusively breastfed and that the lactating mother received iodine supplementation as
indicated above.
3 These figures for iodine supplements are given in situations where complementary food fortified with
iodine is not available, in which case iodine supplementation is required for children of 7–24 months of age.
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Monitoring
Monitoring of IDD prevention and control programmes is
crucial, whether they are based on fortification or
supplementation, in order to ensure that additional iodine
intake is both effective in reducing the deficiency while
preventing excessive intake that may lead to adverse
health consequences. The monitoring process should
include the assessment of coverage and iodine nutrition
status. The detailed methodology of monitoring is given in
ICCIDD/UNICEF/WHO guidelines13.
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